Cargando…

Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study

BACKGROUND: RNA interference (RNAi)-mediated by the expression of short hairpin RNAs (shRNAs) has emerged as a powerful experimental tool for reverse genetic studies in mammalian cells. A number of recent reports have described approaches allowing regulated production of shRNAs based on modified RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pluta, Krzysztof, Diehl, William, Zhang, Xian-Yang, Kutner, Robert, Bialkowska, Agnieszka, Reiser, Jakob
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959519/
https://www.ncbi.nlm.nih.gov/pubmed/17634114
http://dx.doi.org/10.1186/1472-6750-7-41
_version_ 1782134632640151552
author Pluta, Krzysztof
Diehl, William
Zhang, Xian-Yang
Kutner, Robert
Bialkowska, Agnieszka
Reiser, Jakob
author_facet Pluta, Krzysztof
Diehl, William
Zhang, Xian-Yang
Kutner, Robert
Bialkowska, Agnieszka
Reiser, Jakob
author_sort Pluta, Krzysztof
collection PubMed
description BACKGROUND: RNA interference (RNAi)-mediated by the expression of short hairpin RNAs (shRNAs) has emerged as a powerful experimental tool for reverse genetic studies in mammalian cells. A number of recent reports have described approaches allowing regulated production of shRNAs based on modified RNA polymerase II (Pol II) or RNA polymerase III (Pol III) promoters, controlled by drug-responsive transactivators or repressors such as tetracycline (Tet)-dependent transactivators and repressors. However, the usefulness of these approaches is often times limited, caused by inefficient delivery and/or expression of shRNA-encoding sequences in target cells and/or poor design of shRNAs sequences. With a view toward optimizing Tet-regulated shRNA expression in mammalian cells, we compared the capacity of a variety of hybrid Pol III promoters to express short shRNAs in target cells following lentivirus-mediated delivery of shRNA-encoding cassettes. RESULTS: RNAi-mediated knockdown of gene expression in target cells, controlled by a modified Tet-repressor (TetR) in the presence of doxycycline (Dox) was robust. Expression of shRNAs from engineered human U6 (hU6) promoters containing a single tetracycline operator (TO) sequence between the proximal sequence element (PSE) and the TATA box, or an improved second-generation Tet-responsive promoter element (TRE) placed upstream of the promoter was tight and reversible as judged using quantitative protein measurements. We also established and tested a novel hU6 promoter system in which the distal sequence element (DSE) of the hU6 promoter was replaced with a second-generation TRE. In this system, positive regulation of shRNA production is mediated by novel Tet-dependent transactivators bearing transactivation domains derived from the human Sp1 transcription factor. CONCLUSION: Our modified lentiviral vector system resulted in tight and reversible knockdown of target gene expression in unsorted cell populations. Tightly regulated target gene knockdown was observed with vectors containing either a single TO sequence or a second-generation TRE using carefully controlled transduction conditions. We expect these vectors to ultimately find applications for tight and reversible RNAi in mammalian cells in vivo.
format Text
id pubmed-1959519
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19595192007-08-31 Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study Pluta, Krzysztof Diehl, William Zhang, Xian-Yang Kutner, Robert Bialkowska, Agnieszka Reiser, Jakob BMC Biotechnol Research Article BACKGROUND: RNA interference (RNAi)-mediated by the expression of short hairpin RNAs (shRNAs) has emerged as a powerful experimental tool for reverse genetic studies in mammalian cells. A number of recent reports have described approaches allowing regulated production of shRNAs based on modified RNA polymerase II (Pol II) or RNA polymerase III (Pol III) promoters, controlled by drug-responsive transactivators or repressors such as tetracycline (Tet)-dependent transactivators and repressors. However, the usefulness of these approaches is often times limited, caused by inefficient delivery and/or expression of shRNA-encoding sequences in target cells and/or poor design of shRNAs sequences. With a view toward optimizing Tet-regulated shRNA expression in mammalian cells, we compared the capacity of a variety of hybrid Pol III promoters to express short shRNAs in target cells following lentivirus-mediated delivery of shRNA-encoding cassettes. RESULTS: RNAi-mediated knockdown of gene expression in target cells, controlled by a modified Tet-repressor (TetR) in the presence of doxycycline (Dox) was robust. Expression of shRNAs from engineered human U6 (hU6) promoters containing a single tetracycline operator (TO) sequence between the proximal sequence element (PSE) and the TATA box, or an improved second-generation Tet-responsive promoter element (TRE) placed upstream of the promoter was tight and reversible as judged using quantitative protein measurements. We also established and tested a novel hU6 promoter system in which the distal sequence element (DSE) of the hU6 promoter was replaced with a second-generation TRE. In this system, positive regulation of shRNA production is mediated by novel Tet-dependent transactivators bearing transactivation domains derived from the human Sp1 transcription factor. CONCLUSION: Our modified lentiviral vector system resulted in tight and reversible knockdown of target gene expression in unsorted cell populations. Tightly regulated target gene knockdown was observed with vectors containing either a single TO sequence or a second-generation TRE using carefully controlled transduction conditions. We expect these vectors to ultimately find applications for tight and reversible RNAi in mammalian cells in vivo. BioMed Central 2007-07-16 /pmc/articles/PMC1959519/ /pubmed/17634114 http://dx.doi.org/10.1186/1472-6750-7-41 Text en Copyright © 2007 Pluta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pluta, Krzysztof
Diehl, William
Zhang, Xian-Yang
Kutner, Robert
Bialkowska, Agnieszka
Reiser, Jakob
Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
title Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
title_full Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
title_fullStr Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
title_full_unstemmed Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
title_short Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
title_sort lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959519/
https://www.ncbi.nlm.nih.gov/pubmed/17634114
http://dx.doi.org/10.1186/1472-6750-7-41
work_keys_str_mv AT plutakrzysztof lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy
AT diehlwilliam lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy
AT zhangxianyang lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy
AT kutnerrobert lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy
AT bialkowskaagnieszka lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy
AT reiserjakob lentiviralvectorsencodingtetracyclinedependentrepressorsandtransactivatorsforreversibleknockdownofgeneexpressionacomparativestudy